Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Baird Maintains Outperform on Albireo Pharma, Raises Price Target to $55

Baird analyst Brian Skorney maintains Albireo Pharma (NASDAQ:ALBO) with a Outperform and raises the price target from $43 to $55.

byBenzinga Newsdesk

October 12, 2022

1 minute read

Baird analyst Brian Skorney maintains Albireo Pharma (NASDAQ:ALBO) with a Outperform and raises the price target from $43 to $55.

Aspen Group Q1 EPS $(0.03) Beats $(0.05) Estimate, Sales $19.40M Beat $19.23M Estimate

By Bill Haddad

Today, 10:08 PM

Aspen Group (NASDAQ:ASPU) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.05) by 40 percent. The company reported quarterly sales of $19.40 million which beat the analyst

ASPU

News

Why Exxon Mobil Shares Are Rising

By Henry Khederian

Today, 10:08 PM

Shares of several oil & gas companies, including Exxon Mobil Corporation (NYSE: XOM), are trading higher Friday as oil prices rise on OPEC+ supply curbs.

XOM